Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
125
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
NIFTY Index
•
05 Oct 2024 07:00
EQD | Is the NIFTY A BUY Here?
The NIFTY Index closed the week down, now the question is: IS THIS A GOOD TIME TO (RE)ENTER LONG? As always, the Market Reversal Matrix models...
Nico Rosti
Follow
747 Views
Share
bearish
•
NTPC
•
26 Sep 2024 09:54
NIFTY Indices: Flows (Post Capping) At the Close Tomorrow; Round-Trip US$3.3bn
The next rebalance of the Nifty family of indices takes place at the close on 27 Sep. The round-trip trade is US$3.3bn and there are 13 stocks with...
Brian Freitas
Follow
790 Views
Share
bearish
•
Divi's Laboratories
•
23 Sep 2024 14:15
Quiddity NIFTY Sep 24 Rebal: US$647mn One-Way Capping for NIFTY Next 50; All Changes Were Predicted
The NIFTY50/NIFTY Next 50 Inclusion/Exclusion events will take place at the close of 27th September 2024. The final capping flows will be decided...
Janaghan Jeyakumar, CFA
Follow
897 Views
Share
bullish
•
Bharat Heavy Electricals
•
26 Aug 2024 05:50
NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines
There are 7 changes for the NIFTY Next50 Index. Estimated 1-way turnover is 19.6% resulting in a 1-way trade of INR 63.64bn (US$759m). There are...
Brian Freitas
Follow
851 Views
Share
bullish
•
Trent
•
25 Aug 2024 08:00
NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree
Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...
Brian Freitas
Follow
715 Views
Share
First
Previous
12
13
14
15
16
17
18
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x